Clinical trials
Phase 1/2 Rectal Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
65 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 6 |
| 2001 | 4 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 4 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 5 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 36 |
| Recruiting | 9 |
| Terminated | 9 |
| Active, not recruiting | 6 |
| Unknown status | 3 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 11 |
| M.D. Anderson Cancer Center | 4 |
| Roswell Park Cancer Institute | 4 |
| Gilead Sciences | 3 |
| Memorial Sloan Kettering Cancer Center | 3 |
| A2 Biotherapeutics Inc. | 2 |
| City of Hope Medical Center | 2 |
| GlaxoSmithKline | 2 |
| The University of Texas Health Science Center at San Antonio | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rectal Neoplasms | 65 |
| Colonic Neoplasms | 57 |
| Colorectal Neoplasms | 42 |
| Pancreatic Neoplasms | 14 |
| Carcinoma, Non-Small-Cell Lung | 8 |
| Neoplasm Metastasis | 8 |
| Breast Neoplasms | 7 |
| Stomach Neoplasms | 7 |
| Carcinoma, Renal Cell | 6 |
| Lung Neoplasms | 6 |
Trials
Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.